Condition: Mitral Regurgitation · Sponsor: Shanghai NewMed Medical Co., Ltd.
The purpose of this clinical trial is to evaluate the effectiveness and safety of the transcatheter mitral valve repair system in the treatment of patients with moderate or above degenerative mitral regurgitation.
This description comes directly from the study's public registry record.
chunyang Wang, CRA · (86)-21-20788668 · cywang@newmed.cn
xuyang Xie · (86)-21-20788668 · xyxie@newmed.cn
Always discuss trial participation with your own doctor first.
| Department of Cardiology, West China Hospital, Sichuan University | Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05021614